Journal of the American Society of Hypertension 7(6) (2013) 516–520

SUBJECT INDEX

A

ACE2. see Angiotensin-converting en-zyme 2

Adolescenceis not an independent risk factor for renal

cancer, hypertension in, 283–288African-Americanshypertensive, with metabolic syn-

drome, amlodipine/olmesartan ver-sus hydrochlorothiazide/losartan onchanges in biomarkers and 24 hoursblood pressure in, 386–394

Agingnormal process, with a premature

increase in left atrial volume, hyper-tension accelerates the, 149–156

Amlodipineolmesartan, and hydrochlorothiazide in

study participants with hypertensionand diabetes, efficacy and safety oftriple-combination therapy with,325 (erratum)

and olmesartan, versus hydrochlorothi-azide/losartan, on changes in bio-markers and 24 hours bloodpressure in hypertensive AfricanAmericans with metabolic syn-drome, 386–394

with olmesartan, compared with mono-therapy, variation of some inflam-matory markers in hypertensivepatients after 1 year of combinationtherapy of, 32–39

and perindopril, on blood pressurecontrol in 6256 patients with not-at-goal hypertension, effect of fixedcombination of, 163–169

Angiogenesisand serum peroxides in a bi-ethnic pop-

ulation from South Africa, explor-ing the link between, 267–275

Angiotensin-converting enzyme 2(ACE2)deficiency, induced perivascular fibro-

sis and cardiac hypertrophy duringpostnatal development in mice,259–266

Angiotensin II1-12, metabolism in normal human

hearts, chymase mediates, 128–136

1933-1711/$ - see front matter � 2013 Americ

can signal from outside and inside ofcell, 253–255

intracellular, increases the total potas-sium current and resting potentialof arterial myocytes from vascularresistance vessels of rat, 192–197

Angiotensin II type 2 receptorduring regression of cardiac hypertro-

phy in spontaneously hypertensiverats, role of, 118–127

Antihypertensive agentscombination therapy for hypertension,

401–407in diabetic hypertensive patients,

perception of uncontrolled bloodpressure and non-adherence to,477–483

medication in older adults, safetyand blood pressure trajectory ofshort-term withdrawal of, 289–293

prevalence of white coat hypertensionbefore and after therapy of,236–243

Arginine vasopressinV1A and V2 receptors, in rats with ge-

netic hypertension, age-dependentregulation of, 3–13

Arterial myocytesfrom vascular resistance vessels of rat,

intracellular angiotensin II increasesthe total potassium current andresting potential of, 192–197

Arterial stiffnessevaluation by cardio-ankle vascular

index in hypertension and diabetesmellitus subjects, 426–431

Atherosclerotic renal artery diseaselong-term follow-up of patients with,

24–31

B

Beta-blockerson myocardial mRNA expressions of

circadian rhythm and metabolism-related genes, influence of, 107–117

Birthcountry of, impact on progression of

steady and pulsatile hemodynamicparameters in normotensive andhypertensive subjects, 440–447

an Society of Hypertension. All rights reserved.

Blood pressureautomated, monitors outperform mer-

cury, 448–453and cardiac function, on brain volume

and white matter hyperintensitiesin heart failure, independent andinteractive effects of, 336–343

central and peripheral arterial, genderdifference between, 379–385

control in 6256 patients with not-at-goal hypertension, effect of fixedcombination of perindopril andamlodipine on, 163–169

dipping, reproducibility in relationto day-to-day variability in sleepquality, 432–439

24 hours, and biomarkers, in hyper-tensive African Americans withmetabolic syndrome, amlodipine/olmesartan versus hydrochloro-thiazide/losartan on changes in,386–394

is modulated by gender and age but notby BMI in large Taiwanese popula-tion, 1996–2006, seasonal variationin, 216–228

measured, and self-reported hyperten-sion status, in stroke belt, predictorsof congruency between, 370–378

and safety, trajectory of short-termwithdrawal of antihypertensivemedications in older adults, 289–293

uncontrolled, and non-adherence toanti-hypertensive agents in diabetichypertensive patients, perceptionof, 477–483

uncontrolled ambulatory, and highmedication adherence, characteris-tics, drug combinations and dosagesof primary care patients with,471–476

and vascular function, potential bene-fits of exercise on, 494–506

BMI. see Body mass index

Body mass indexin large Taiwanese population, 1996-

2006, seasonal variation in bloodpressure is modulated by genderand age but not by, 216–228

517Subject Index / Journal of the American Society of Hypertension 7(6) (2013) 516–520

Brain volumeand white matter hyperintensities, in

heart failure, independent and inter-active effects of blood pressure andcardiac function on, 336–343

C

Cardiac functionand blood pressure, on brain volume

and white matter hyperintensitiesin heart failure, independent andinteractive effects of, 336–343

Cardiac hypertrophyand perivascular fibrosis during postna-

tal development in mice, ACE2deficiency induced, 259–266

Cardio-ankle vascular indexin hypertension and diabetes mellitus

subjects, arterial stiffness evaluationby, 426–431

Cardiovascular diseaseeffects of pharmacologic therapies for

smoking cessation in patients with,61–67

new insights into the true nature ofobesity as risk factor for, 85–94

Cardiovascular responseto dietary sodium chloride, dietary po-

tassium key mediator of, 395–400Cerebrovascular diseaseand gene alterations, in Cyp1a1-Ren2

transgenic rats, controlled hyperten-sion induces, 411–419

and medication adherence, risk intreated hypertensives, 363–369

Childrenwith hypertension, multicenter study of

neurocognition in, 353–362Chymasemediates angiotensin-(1-12) metabolism

in normal human hearts, 128–136Circadian rhythmand metabolism-related genes, influ-

ence of beta-blockers on myocardialmRNA expressions of, 107–117

Cyp1a1-Ren2transgenic rats, controlled hypertension

induces cerebrovascular and genealterations in, 411–419

Cytokinesangiogenic, in renovascular disease,

180–190

D

Diabetes mellituseffect of obesity in impaired glucose

homeostasis in non-diabetic Greekhypertensives with family historyof, 294–304

and hypertension, arterial stiffnessevaluation by cardio-ankle vascularindex in subjects with, 426–431

and hypertension, efficacy and safetyof triple-combination therapy witholmesartan, amlodipine, and hydro-chlorothiazide in study participantswith, 325 (erratum)

perception of uncontrolled bloodpressure and non-adherence toanti-hypertensive agents in patientswith, 477–483

Drug therapy, combinationwith olmesartan/amlodipine compared

with monotherapy, variation of someinflammatory markers in hyperten-sive patients after 1 year of, 32–39

of perindopril and amlodipine onblood pressure control in 6256 pa-tients with not-at-goal hypertension,effect of, 163–169

triple, in hypertension, treatment adher-ence, clinical outcomes, and eco-nomics of, 46–60

E

Essential hypertensionassociation of sodium and potassium

intake with ventricular arrhythmicburden in patients with, 276–282

Exerciseon blood pressure and vascular func-

tion, potential benefits of, 494–506hypertension induced by, among

healthy firefighters, 40–45and impaired left ventricular longi-

tudinal functional reserve inhypertension, relationship betweenventricular-vascular uncouplingduring, 198–205

F

Family historyof diabetes, effect of obesity in impaired

glucose homeostasis in non-diabeticGreek hypertensives with, 294–304

Fasting plasma glucoseand serum potassium, effects of low-

dose thiazide diuretics on, 454–466Furosemidefor your mother, 507–508 (Editorials)

G

Genderand age but not by BMI in large

Taiwanese population, 1996–2006,seasonal variation in blood pressureis modulated by, 216–228

Gene alterationsand cerebrovascular, in Cyp1a1-Ren2

transgenic rat, controlled hyperten-sion induces, 411–419

H

Heartnormal, human, chymase mediates

angiotensin-(1-12) metabolism in,128–136

Heart failureindependent and interactive effects of

blood pressure and cardiac functionon brain volume and white matterhyperintensities in, 336–343

Heme oxygenase-2 deficiencyon renovascular hypertension, sex-

specific effects of, 328–335Hemodynamicscirculatory patterns in young patients

with predominantly diastolic hyper-tension, 157–162

steady and pulsatile parameters, innormotensive and hypertensive sub-jects, impact of country of birth onprogression of, 440–447

Hispanic Americansand non-Hispanic blacks, salt sensiti-

vity in, 170–179Hydrochlorothiazideand losartan, versus amlodipine/olme-

sartan, on changes in biomarkersand 24 hours blood pressure inhypertensive African Americanswith metabolic syndrome, 386–394

olmesartan, and Amlodipine in studyparticipants with hypertension anddiabetes, efficacy and safety oftriple-combination therapy with,325 (erratum)

Hypercholesterolemiaand hypertension, impaired vasomotor

function induced by the combina-tion of, 14–23

Hypertensionaccelerates the normal aging process

with a premature increase in leftatrial volume, 149–156

in adolescence is not an independentrisk factor for renal cancer, 283–288

in African Americans with metabolicsyndrome, amlodipine/olmesartanversus hydrochlorothiazide/losartanon changes in biomarkers and 24hours blood pressure in, 386–394

after 1 year of olmesartan/amlodipinecombination compared with mono-therapy, variation of some inflam-matory markers in, 32–39

518 Subject Index / Journal of the American Society of Hypertension 7(6) (2013) 516–520

antihypertensive combination therapyfor, 401–407

apparent and true resistant, 509–511(Editorials)

arterial, prevalent, underreported, andsometimes underestimated associa-tion of nocturia in, 75–84

common molecular mechanisms coor-dinating diverse organ and cellularevents in, 68–74

controlled, induces cerebrovascular andgene alterations in Cyp1a1-Ren2transgenic rats, 411–419

and diabetes, efficacy and safety oftriple-combination therapy witholmesartan, amlodipine, and hydro-chlorothiazide in study participantswith, 325 (erratum)

and diabetes mellitus, arterial stiffnessevaluation by cardio-ankle vascularindex in subjects with, 426–431

diastolic, hemodynamic circulatorypatterns in young patients with,157–162

early predictors of alterations in leftatrial structure and function relatedto left ventricular dysfunctionin asymptomatic patients with,206–215

essential, association of sodium andpotassium intake with ventriculararrhythmic burden in patients with,276–282

genetic, age-dependent regulation ofrenal vasopressin V1A and V2 recep-tors in rats with, 3–13

Greek, non-diabetic, with diabetesfamily history, effect of obesityin impaired glucose homeostasison, 294–304

and hypercholesterolemia, impairedvasomotor function induced by thecombination of, 14–23

induced by exercise, among healthyfirefighters, 40–45

masked, recognition and managementof, 244–252

medication adherence and stroke/TIArisk in treated, 363–369

multicenter study of neurocognition inchildren with, 353–362

and normotensive, impact of country ofbirth on progression of steady andpulsatile hemodynamic parametersin subjects with, 440–447

not-at-goal, effect of fixed combinationof perindopril and amlodipine onblood pressure control in 6256patients with, 163–169

perception of uncontrolled bloodpressure and non-adherence toanti-hypertensive agents in patientswith, 477–483

relationship between ventricular-vascu-lar uncoupling during exercise andimpaired left ventricular longitudi-nal functional reserve in, 198–205

renovascular, sex-specific effects ofheme oxygenase-2 deficiency on,328–335

resistant, prevalence and characteristicsof pseudohypertension in patientswith, 467–470

sarcopenic obesity as an independentrisk factor of, 420–425

severe and resistant, review of state ofrenal nerve ablation for patientswith, 484–493

spontaneously, role of angiotensin IItype 2 receptor during regressionof cardiac hypertrophy in, 118–127

status of, self-reported, and measuredblood pressure, in stroke belt,predictors of congruency between,370–378

systemic, in Saudi Arabia, assessingthe role of optometrists in thecontrol of, 305–316

treatment adherence, clinical outcomes,and economics of triple-drug ther-apy in, 46–60

treatment-resistant, lessons learned ina study of, 95–101

white coat, before and after anti-hypertensive therapy, prevalenceof, 236–243

women, with low magnesium levels,altered vascular structure and wavereflection in, 344–352

Hypertrophycardiac, in spontaneously hypertensive

rats, role of angiotensin II type2 receptor during regression of,118–127

I

Impaired glucose toleranceof non-diabetic Greek hypertensives

with diabetes family history, effectof obesity in, 294–304

J

Journal of the American Society ofHypertensionsynopsis on the studies and reviews

included in the issue of, 1–2(Editorials), 105–106 (Editorials),

191 (Editorials), 257–258 (Edito-rials), 327 (Editorials), 409–410(Editorials)

L

Left atrial dilatationhypertension accelerates the normal

aging process with a prematureincrease in, 149–156

Losartanand hydrochlorothiazide, versus amlodi-

pine/olmesartan, on changes in bio-markers and 24 hours blood pressurein hypertensive African Americanswith metabolic syndrome, 386–394

M

Magnesiumlow levels of, altered vascular structure

and wave reflection in hypertensivewomen with, 344–352

Medication adherencehigh, and uncontrolled ambulatory

blood pressure, characteristics,drug combinations and dosages ofprimary care patients with, 471–476

and stroke/TIA, risk in treated hyper-tensives, 363–369

Mercuryautomated blood pressure monitors

outperform, 448–453Metabolic syndromeamlodipine/olmesartan versus hydro-

chlorothiazide/losartan on changesin biomarkers and 24 hours bloodpressure in hypertensive AfricanAmericans with, 386–394

telmisartan the first meta-analysis ofrandomized controlled trials in,229–235

Metabolismrelated genes, and circadian rhythm, in-

fluence of beta-blockers on myocar-dial mRNA expressions of, 107–117

Monotherapyvariation of some inflammatory

markers in hypertensive patients af-ter 1 year of olmesartan/amlodipinecombination compared with, 32–39

mRNA expressionmyocardial, of circadian rhythm and

metabolism-related genes, influenceof beta-blockers on, 107–117

N

Neurocognitionin children with hypertension, multi-

center study of, 353–362

519Subject Index / Journal of the American Society of Hypertension 7(6) (2013) 516–520

Nocturiain arterial hypertension, prevalent,

underreported, and sometimesunderestimated association of, 75–84

O

Obesityeffects in impaired glucose homeosta-

sis of non-diabetic Greek hyperten-sives with diabetes family history,294–304

and overweight pregnant women,serum placental growth factor asa predictor of early onset pre-eclampsia in, 137–148

as risk factor for cardiovasculardisease, new insights into the truenature of, 85–94

sarcopenic, as an independent riskfactor of hypertension, 420–425

Olmesartanamlodipine, and hydrochlorothiazide in

study participants with hypertensionand diabetes, efficacy and safetyof triple-combination therapy with,325 (erratum)

and amlodipine, versus hydrochloro-thiazide/losartan, on changes in bio-markers and 24 hours blood pressurein hypertensive African Americanswith metabolic syndrome, 386–394

with amlodipine, compared with mono-therapy, variation of some inflam-matory markers in hypertensivepatients after 1 year of combinationtherapy of, 32–39

Optometristsassessing the role in the control of

systemic hypertension in SaudiArabia, 305–316

Orthostatic hypotensionevaluation and treatment of, 317–324

Overweightand obese pregnant women, serum

placental growth factor as a predic-tor of early onset preeclampsia in,137–148

P

Perindopriland amlodipine, on blood pressure

control in 6256 patients with not-at-goal hypertension, effect of fixedcombination of, 163–169

Perivascular fibrosisand cardiac hypertrophy during postna-

tal development in mice, ACE2deficiency induced, 259–266

Placental growth factorserum, as a predictor of early onset

preeclampsia in overweight/obesepregnant women, 137–148

Postnatal developmentin mice, ACE2 deficiency induced

perivascular fibrosis and cardiachypertrophy during, 259–266

Potassiumdietary, key mediator of cardiovascular

response to dietary sodium chloride,395–400

serum, and fasting plasma glucose,effects of low-dose thiazide di-uretics on, 454–466

Potassium channelstotal current, and resting potential of

arterial myocytes from vascular re-sistance vessels of rat, intracellularangiotensin II increases the, 192–197

Potassium intakeand sodium with ventricular arrhythmic

burden in patients with essential hy-pertension, association of, 276–282

Preeclampsiaearly onset, in overweight/obese

pregnant women, serum placentalgrowth factor as a predictor of,137–148

Pregnancyin overweight/obese women, serum

placental growth factor as a predic-tor of early onset preeclampsia in,137–148

Primary carein patients with uncontrolled

ambulatory blood pressure andhigh medication adherence, charac-teristics, drug combinations anddosages of, 471–476

Pseudohypertensionin patients with ’’resistant hyperten-

sion’’, prevalence and characteris-tics of, 467–470

R

Race/ethnicityfrom South Africa, exploring the link

between serum peroxides andangiogenesis in, 267–275

Renal cancerhypertension in adolescence is not

an independent risk factor for,283–288

Renal nerve ablationfor patients with severe and resistant

hypertension, review of state of,484–493

Renovascular diseaseangiogenic cytokines in, 180–190

Reproducibilityof blood pressure dipping in relation to

day-to-day variability in sleepquality, 432–439

Risk factorfor cardiovascular disease, new insights

into the true nature of obesity as,85–94

independent, of hypertension, sarco-penic obesity as an, 420–425

for renal cancer, hypertension inadolescence is not an independent,283–288

in treated hypertensives, medicationadherence and stroke/TIA risk in,363–369

S

Salt sensitivityin Hispanic and non-Hispanic blacks,

170–179Saudi Arabiaassessing the role of optometrists in the

control of systemic hypertension in,305–316

Serum peroxidesand angiogenesis in a bi-ethnic popula-

tion from South Africa, exploringthe link between, 267–275

Sex differencebetween central and peripheral arterial

blood pressure, 379–385effects of heme oxygenase-2 defici-

ency on renovascular hypertension,328–335

Sleep qualityreproducibility of blood pressure

dipping in relation to day-to-dayvariability in, 432–439

Smoking cessationin patients with cardiovascular disease,

effects of pharmacologic therapiesfor, 61–67

Sodium chloridedietary, potassium key mediator of

cardiovascular response to, 395–400Sodium intakeand potassium with ventricular arrhy-

thmic burden in patients withessential hypertension, associationof, 276–282

South Africaexploring the link between serum

peroxides and angiogenesis in a bi-ethnic population from, 267–275

Stroke. see Cerebrovascular disease

520 Subject Index / Journal of the American Society of Hypertension 7(6) (2013) 516–520

Stroke beltpredictors of congruency between

self-reported hypertension statusand measured blood pressure in,370–378

T

Taiwanseasonal variation in blood pressure is

modulated by gender and age butnot by BMI in large population,1996–2006 in, 216–228

Telmisartanthe first meta-analysis of randomized

controlled trials in metabolic syn-drome, 229–235

Thiazide diureticslow-dose, effects on fasting plasma

glucose and serum potassium,454–466

TIA. see Transient ischemic attack

Transient ischemic attackand medication adherence, risk in

treated hypertensives, 363–369

V

Vascular functionand blood pressure, potential benefits

of exercise on, 494–506Vascular resistanceof rat, intracellular angiotensin II

increases the total potassium currentand resting potential of arterialmyocytes from, 192–197

Vasomotor functionimpaired, induced by the combination

of hypertension and hypercholester-olemia, 14–23

Ventricular arrhythmiain patients with essential hypertension,

association of sodium and potas-sium intake with, 276–282

Ventricular dysfunction, leftin asymptomatic patients with hyper-

tension, early predictors ofalterations in left atrial structure andfunction related to, 206–215

and exercise, in hypertension, relation-ship between ventricular-vascularuncoupling during, 198–205

Ventricular-vascular interactionduring exercise and impaired left

ventricular longitudinal functionalreserve in hypertension, relationshipbetween, 198–205

W

White matter hyperintensityand brain volume, in heart failure,

independent and interactive effectsof blood pressure and cardiac func-tion on, 336–343